The renin–angiotensin–aldosterone system (RAAS) plays a key role during development
and in the day-to-day maintenance of blood pressure, sodium, and electrolyte homeostasis …

Background There is no commonly shared severity score for myxomatous mitral valve
disease (MMVD) based on routinely acquired echocardiographic variables …

Radiographic assessment of heart size is important for clinical management of dogs with
cardiovascular disease (CVDz). We sought to compare the ability of vertebral heart size …

Background Predicting progression of myxomatous mitral valve disease (MMVD) in dogs
can be challenging. Hypothesis/Objectives The mitral regurgitation severity index (MRSI) will …

Degenerative valve disease (DVD) is the leading cause of heart disease and heart failure in
dogs and has many recognized aliases, including myxomatous mitral valve disease, chronic …

Background In humans, lung congestion scores are predictive of recurrence of acute
congestive heart failure (CHF) and are superior to cardiac biomarkers in predicting survival …

Background Angiotensin‐converting enzyme inhibitors (ACEIs) are commonly prescribed in
dogs, but the ideal dosage is unknown. Hypothesis/Objectives In dogs with cardiac disease …

Background The behavior of the comprehensive circulating renin‐angiotensin system (RAS)
in dogs with myxomatous mitral valve disease (MMVD) before to the onset of congestive …

Simple Summary Myxomatous mitral valve disease (MMVD) is the most commonly acquired
cardiac disease in dogs and is responsible for congestive heart failure. In this research …

Introduction Two radiographic measures of the left atrial (LA) size, the vertebral left atrial size
(VLAS) and the radiographic left atrial dimension (RLAD), have been described in dogs. The …